Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
120.77
128.94
8.57
63.57
20.34
0.00
0.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
120.77
128.94
8.57
63.57
20.34
0.00
0.00
Raw Material Cost
21.21
21.01
8.89
14.57
11.38
9.87
8.11
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
3.79
4.62
5.29
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
22.29
38.53
49.80
54.44
67.42
54.53
71.48
Other Expenses
2.37
14.31
21.39
26.91
28.20
24.47
21.61
Total Expenditure (Excl Depreciation)
71.00
207.27
277.85
338.12
360.80
309.05
295.68
Operating Profit (PBDIT) excl Other Income
49.800000000000004
-78.3
-269.3
-274.5
-340.5
-309.1
-295.7
Other Income
3.25
2.64
5.18
52.22
0.37
2.45
4.72
Operating Profit (PBDIT)
53.66
-72.99
-259.27
-207.76
-328.71
-296.74
-282.86
Interest
3.79
4.62
5.29
0.00
0.00
0.00
0.00
Exceptional Items
-16.51
-5.11
-6.73
-5.96
0.00
0.00
0.00
Gross Profit (PBDT)
99.56
107.93
-0.31
49.01
8.96
-9.87
-8.11
Depreciation
0.64
2.70
4.83
14.57
11.38
9.87
8.11
Profit Before Tax
32.72
-85.42
-276.11
-228.29
-340.10
-306.61
-290.96
Tax
0.03
-0.01
0.01
0.01
0.05
0.01
0.01
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
32.69
-85.40
-276.13
-228.30
-340.14
-306.62
-290.98
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
32.69
-85.40
-276.13
-228.30
-340.14
-306.62
-290.98
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
32.69
-85.40
-276.13
-228.30
-340.14
-306.62
-290.98
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
-38.50
-97.28
-99.23
126.64
279.61
462.34
290.78
Earnings per share (EPS)
2.57
-11.41
-65.18
-2.24
-3.63
-4.14
-5.67
Diluted Earnings per share
2.57
-11.41
-65.18
-2.24
-3.63
-4.14
-5.67
Operating Profit Margin (Excl OI)
41.21%
-60.75%
-3140.98%
-431.86%
-1673.85%
0.0%
0.0%
Gross Profit Margin
27.62%
-64.15%
-3164.38%
-336.18%
-1616.1%
0.0%
0.0%
PAT Margin
27.07%
-66.23%
-3220.88%
-359.12%
-1672.28%
0.0%
0.0%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is -6.28% vs 1,398.84% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 138.29% vs 69.07% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 166.67% vs 71.41% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is -17.39% vs -13.21% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Atara Biotherapeutics, Inc. With
Figures in Million
Consolidate Annual Results
Change(USD)
Change(%)
Net Sales
120.77
80.75
40.02
49.56%
Other Operating Income
0.00
0.00
0.00
Total Operating income
120.77
80.75
40.02
49.56%
Raw Material Cost
21.21
19.58
1.63
8.32%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
3.79
10.19
-6.40
-62.81%
Selling and Distribution Expenses
22.29
46.02
-23.73
-51.56%
Other Expenses
2.37
0.64
1.73
270.31%
Total Expenditure (Excl Depreciation)
71.00
82.22
-11.22
-13.65%
Operating Profit (PBDIT) excl Other Income
49.77
-1.47
51.24
3,485.71%
Other Income
3.25
0.12
3.13
2,608.33%
Operating Profit (PBDIT)
53.66
7.39
46.27
626.12%
Interest
3.79
10.19
-6.40
-62.81%
Exceptional Items
-16.51
-8.51
-8.00
-94.01%
Gross Profit (PBDT)
99.56
61.17
38.39
62.76%
Depreciation
0.64
8.75
-8.11
-92.69%
Profit Before Tax
32.72
-20.05
52.77
263.19%
Tax
0.03
0.09
-0.06
-66.67%
Provisions and contingencies
0
0
0.00
Profit After Tax
32.69
-20.13
52.82
262.39%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
32.69
-20.13
52.82
262.39%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
32.69
-20.13
52.82
262.39%
Equity Capital
0
0
0.00
Face Value
0.00
0.01
0.00
Reserves
-38.50
46.17
-84.67
-183.39%
Earnings per share (EPS)
2.57
-0.84
3.41
405.95%
Diluted Earnings per share
2.57
-0.84
3.41
405.95%
Operating Profit Margin (Excl OI)
41.21%
-1.82%
0.00
43.03%
Gross Profit Margin
27.62%
-13.99%
0.00
41.61%
PAT Margin
27.07%
-24.93%
0.00
52.00%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 12.08 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -6.28% vs 1,398.84% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 3.27 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 138.29% vs 69.07% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 5.04 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 166.67% vs 71.41% in Dec 2024
Annual - Interest
Interest 0.38 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -17.39% vs -13.21% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 41.21%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
